Regulatory Environment and Approvals in Cell and Gene Therapy Products Between Japan, the USA, and the EU.
Yuya SatoShunsuke OnoPublished in: Therapeutic innovation & regulatory science (2022)
Our study showed differences of regulations on CGT products and of features in approved products as well as the trend of their home market entries, which may have been driven by a different context than that of traditional pharmaceuticals.